Abbott India Limited Share Price NSE India S.E.

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Delayed NSE India S.E. 11:02:28 29/04/2024 BST 5-day change 1st Jan Change
26,290 INR +1.52% Intraday chart for Abbott India Limited -0.10% +15.05%

Financials

Sales 2024 * 58.91B 706M 56.36B Sales 2025 * 65.79B 789M 62.94B Capitalization 550B 6.59B 526B
Net income 2024 * 11.88B 142M 11.36B Net income 2025 * 13.45B 161M 12.87B EV / Sales 2024 * 8.94 x
Net cash position 2024 * 22.66B 272M 21.68B Net cash position 2025 * 26.6B 319M 25.45B EV / Sales 2025 * 7.95 x
P/E ratio 2024 *
46.1 x
P/E ratio 2025 *
40.6 x
Employees 3,700
Yield 2024 *
1.13%
Yield 2025 *
1.3%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.52%
1 week-0.10%
Current month-3.06%
1 month-4.48%
3 months+2.82%
6 months+16.94%
Current year+15.05%
More quotes
1 week
25 200.00
Extreme 25200
26 506.95
1 month
25 200.00
Extreme 25200
27 700.00
Current year
22 761.10
Extreme 22761.1
29 638.95
1 year
20 605.05
Extreme 20605.05
29 638.95
3 years
14 850.00
Extreme 14850
29 638.95
5 years
7 160.00
Extreme 7160
29 638.95
10 years
1 705.00
Extreme 1705
29 638.95
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/12/94
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 31/03/19
Chairman 81 31/12/67
Director/Board Member 67 31/12/95
More insiders
Date Price Change Volume
29/04/24 26,290 +1.52% 15 391
26/04/24 25,895 +0.86% 7,664
25/04/24 25,674 +0.87% 23,811
24/04/24 25,453 -1.06% 16,823
23/04/24 25,725 -2.25% 34,185

Delayed Quote NSE India S.E., April 29, 2024 at 11:02 am

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings